Introduction
============

*Helicobacter pylori,* a spiral, Gram-negative, microaerophilic bacterium, is a human pathogen responsible for chronic active gastritis, and infection with this organism is an important risk factor for the development of peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue lymphoma [1](#R1){ref-type="bib"} [2](#R2){ref-type="bib"} [3](#R3){ref-type="bib"} [4](#R4){ref-type="bib"} [5](#R5){ref-type="bib"}. Several putative *H*. *pylori* virulence factors have been identified, including urease, the vacuolating cytotoxin VacA, and the cytotoxin-associated gene A antigen CagA [6](#R6){ref-type="bib"} [7](#R7){ref-type="bib"}. Most of the clinical isolates of *H*. *pylori* from patients suffering from peptic ulcer or malignant disease express these virulence-associated factors [8](#R8){ref-type="bib"} [9](#R9){ref-type="bib"}. *H*. *pylori* strains may be divided into two broad families, type I and type II, based on whether or not they possess the *cag* pathogenicity island (PAI). Type I strains are those that contain the *cag* PAI, whereas type II strains lack functional *cag* PAI [10](#R10){ref-type="bib"}. Serological studies have indicated that patients with duodenitis, duodenal ulcers, and gastric tumors are most often infected by type I *H*. *pylori* strains. In the mouse model, type I *H*. *pylori* strains can induce visible gastric damage, whereas type II strains do not induce dramatic changes [9](#R9){ref-type="bib"}. These studies thus suggest that Cag proteins, including CagA encoded by the *cag* PAI, play important roles in the pathogenicity of *H*. *pylori* [8](#R8){ref-type="bib"} [9](#R9){ref-type="bib"} [11](#R11){ref-type="bib"} [12](#R12){ref-type="bib"}.

*H*. *pylori* attaches specifically and tightly to gastric epithelial cells. The adherence of *H*. *pylori* to the gastric epithelial cells is an important determinant of pathogenesis. Bacterial attachment causes microvilli effacement, actin rearrangement, pedestal formation, and induction of IL-8 release [13](#R13){ref-type="bib"}, although the precise mechanisms of *H*. *pylori* adherence are still poorly understood. Previous studies have reported that attachment of *H*. *pylori* to cultured gastric epithelial cells such as AGS cells can induce tyrosine phosphorylation of a 145-kD host protein and accumulation of F-actin beneath the bacterium [14](#R14){ref-type="bib"} [15](#R15){ref-type="bib"} and also the subsequent evoked activation of nuclear factor (NF)-κB and release of IL-8 [16](#R16){ref-type="bib"} [17](#R17){ref-type="bib"} [18](#R18){ref-type="bib"}. The ability of bacteria to induce protein tyrosine phosphorylation, IL-8 production, and the rearrangement of actin cytoskeletons is closely correlated with the presence of the ∼40-kb *cag* PAI [7](#R7){ref-type="bib"} [14](#R14){ref-type="bib"} [15](#R15){ref-type="bib"}. It has been suggested that the PAI DNA was inherited by horizontal transfer from an unknown microorganism, and the 31 genes of *cag* are thought to be encoded by a putative type IV secretion system [19](#R19){ref-type="bib"} [20](#R20){ref-type="bib"}. For example, the *cag* homologues of VirB4 (CagE), VirB7 (CagT), VirB9 (*cag*ORF528), VirB10 (*cag*ORF527), VirB11 (*cag*ORF525), and VirD4 (*cag*ORF524) of *Agrobacterium tumefaciens* have been indicated to be assembled as a complex and form the type IV transport machinery [19](#R19){ref-type="bib"} [20](#R20){ref-type="bib"}. Although the notion must still be verified in *H*. *pylori*, it suggests the potential ability of *H*. *pylori* to deliver bacterial effector molecules through the putative type IV secretion system into the attached host cells, thus enabling the bacteria to alter host cell signaling such as that required for protein tyrosine phosphorylation, stimulation of IL-8 release, and induction of actin dynamics [13](#R13){ref-type="bib"} [14](#R14){ref-type="bib"} [15](#R15){ref-type="bib"}. Although the signaling pathways involved in induction of the various cellular responses remain unclear, persistent host cellular responses to bacterial infection are thought to be the basis of chronic active gastritis, peptic ulcer disease, and perhaps the oncogenic transformation that are the hallmarks of symptomatic *H*. *pylori* infection. In this sense, elucidation of the bacterial effector molecules as well as the host cellular responses including signaling pathways must be important. Although the role of IL-8 in promotion of inflammatory reaction to *H*. *pylori* infection has been well studied [16](#R16){ref-type="bib"} [18](#R18){ref-type="bib"} [21](#R21){ref-type="bib"}, the identity and function of the tyrosine-phosphorylated 145-kD protein remains unknown.

In this context, we have attempted to characterize the tyrosine-phosphorylated 145-kD protein induced in gastric epithelial cells by *H*. *pylori* infection. In our study, we provide evidence that the tyrosine-phosphorylated protein is not a host cellular protein but is rather the *cagA* gene product of *H*. *pylori*.

Materials and Methods
=====================

Bacterial Strains, Cell Lines, and Media.
-----------------------------------------

*H*. *pylori* standard strains NCTC11637, NCTC11916, and ATCC43579, and its *cagA*::Km mutant and clinical isolates of *H*. *pylori* from patients with gastric ulcer (GU301, GU303, GU304, GU305, and GU306) or gastric cancer (GC401 and GC402) from Fukui Medical University in Japan were used. Before each experiment, *H*. *pylori* strains were passaged on 5% sheep blood agar plates (Nippon Becton Dickinson Co., Ltd.) by incubation in an atmosphere consisting of 5% O~2~, 15% CO~2~, and 80% N~2~ for 2--4 d at 37°C. Bacteria were cultured in brucella broth (Difco Labs., Inc.) supplemented with 5% FBS (GIBCO BRL) under the same conditions for 12--24 h at 37°C with agitation (80--100 rpm/min). Human gastric adenocarcinoma epithelial MKN45 and AGS cells (ATCC CRL1739) were from the Japanese Cancer Research Resources Bank and the American Type Culture Collection, respectively. MKN45 and AGS cells were cultured in RPMI 1640 (Sigma Chemical Co.) and DME (Nihonseiyaku) containing 10% FBS, respectively.

Antibodies.
-----------

The antiphosphotyrosine antibodies (mAb PY-20 and RC-20; conjugated with horseradish peroxidase) were purchased from Transduction Labs., Inc. Normal rabbit and normal mouse IgG was purchased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal anti-CagA antibody has been described [22](#R22){ref-type="bib"}.

Preparation of Cell Lysates and Immunoprecipitation.
----------------------------------------------------

AGS and MKN45 cells (5 × 10^6^ per plate) cultured to 80% confluence were washed once with 0.1 M PBS, pH 7.5, and then 4 ml of fresh, antibiotic-free DME was added to each 100-mm dish. Cells were infected with *H*. *pylori* at a multiplicity of infection of 20--50. After incubation in a 5% CO~2~ atmosphere for the time indicated in each figure, 5 × 10^6^ infected cells were lysed in ice cold 1% Triton X-100 buffer (50 mM Tris/HCl, pH 7.4, 1% Triton X-100, 5 mM EDTA, 1 mM Na~3~VO~4~, 10 μg/ml leupeptin, 10 μg/ml aprotinine, 100 μM *p*-tosyl-[l]{.smallcaps}-phenylalanine chloromethyl ketone \[TPCK\], 100 μM *p*-tosyl-[l]{.smallcaps}-lysine chloromethyl ketone \[TLCK\], and 1 mM PMSF). The cell lysates were centrifuged at 10,000 *g* for 10 min at 4°C, and the supernatant (1% Triton X-100--soluble fraction) was subsequently immunoprecipitated with the antibodies indicated in each figure or control normal IgG for 2 h at 4°C, after which protein A--Sepharose (Pharmacia Biotech) was added for 30 min at 4°C. The precipitates were washed three times with lysis buffer and once with 10 mM Hepes/NaOH, pH 8.0, and then boiled with electrophoresis SDS sample buffer (2% SDS, 10% glycerol, 5% 2-ME, 0.003% bromophenol blue, and 62.5 mM Tris/HCl, pH 6.8) for 3 min.

Immunoblot Analysis.
--------------------

Equal amounts of samples from whole cell lysates or immunoprecipitates were separated by SDS-PAGE (6.5% or 7.5% polyacrylamide) and blotted onto Immobilon P (Millipore Corp.). The membranes were blocked with 5% skim milk in T-PBS (PBS containing 0.05% Tween 20) and incubated with a primary antibody in T-PBS for 1--2 h at room temperature. After washing with T-TBS (10 mM Tris/HCl, pH 7.4, 100 mM NaCl, 0.05% Tween 20), the membranes were incubated with horseradish peroxidase--conjugated goat anti--rabbit IgG polyclonal antibodies in T-TBS for 30 min and visualized with an enhanced chemiluminescence (ECL) detection system as directed by the manufacturer (Amersham Corp.). In the case of using antiphosphotyrosine RC-20, after decantation of the primary antibody solution, the membrane was washed with T-TBS and visualized with the ECL detection systems described above. The antiphosphotyrosine immunoblots of anti-CagA immunoprecipitates were stripped by incubating the membranes in a removed buffer (2% SDS, 62.5 mM Tris/HCl, pH 6.8, and 100 mM 2-ME) for 30 min at 50°C and reprobed with the anti-CagA polyclonal antibody.

In Vitro Phosphorylation Assay.
-------------------------------

AGS or MKN45 cells (3 × 10^7^) were lysed in 1 ml of ice cold 1% NP-40 buffer (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 50 mM NaF, 10 mM ammonium molybdate, 1 mM Na~3~VO~4~, 10 μg/ml leupeptin, 10 μg/ml aprotinine, 100 μM TLCK, 100 μM TPCK, and 1 mM PMSF) and homogenized in an Ultrasonic Disrupter UD-201 (Tomy) three times for 45 s each time at 4°C. Similarly, *H*. *pylori* standard or clinical isolated strains (3 × 10^9^) were lysed in 1 ml of cold 1% NP-40 buffer and homogenized by the disrupter. The host cell lysates were incubated together with the bacterial lysates for 10 min at 30°C in a phosphorylation reaction buffer (50 mM Hepes, 40 μM ATP, 5 mM MnCl~2~, 100 mM MgCl~2~, 100 μM Na~3~VO~4~). The lysates were boiled with the sample buffer and separated by SDS-PAGE, followed by immunoblotting with antiphosphotyrosine antibody (RC-20) as described above.

Phosphorylation by c-Src Protein Tyrosine Kinase or Epidermal Growth Factor Receptor Protein Tyrosine Kinase In Vitro.
----------------------------------------------------------------------------------------------------------------------

*H*. *pylori* (3 × 10^9^ bacteria per milliliter) suspended in 1% NP-40 (40 μl) was added into 5 μl of 10× phosphorylation reaction buffer (250 mM Tris/HCl, pH 7.2, 400 μM ATP, 62.5 mM MnCl~2~, 312.5 mM MgCl~2~, 5 mM EGTA, 625 μM Na~3~VO~4~) together with 5 μl of human c-Src protein tyrosine kinase (15 U; Upstate Biotechnology Inc.) and incubated for 10 min at 30°C. *H*. *pylori* (3 × 10^9^ bacteria per milliliter) suspended in 1% NP-40 (30 μl) was added to 20 μl of 2.5× phosphorylation reaction buffer (50 mM Hepes, pH 7.4, 100 μM ATP, 5 mM MnCl~2~, 12.5 mM MgCl, 5 mg/ml BSA, 125 μM Na~3~VO~4~) together with 10 μl of epidermal growth factor (EGF) receptor protein tyrosine kinase (1.39 U; Biomol Research Labs., Inc.) and incubated for 10 min at 30°C.

Labeling of H. pylori and Host Cells with \[^35^S\]Methionine.
--------------------------------------------------------------

*H*. *pylori* (10^9^) were incubated in 100 μl of methionine- and FBS-free RPMI medium containing 200 μCi \[^35^S\]methionine (NEN Life Science Products, Inc.) in an atmosphere consisting of 5% O~2~, 15% CO~2~, and 80% N~2~ for 5 h at 37°C. Then, \[^35^S\]methionine-labeled *H*. *pylori* were washed three times with PBS and resuspended in fresh RPMI containing 10% FBS. After the addition of \[^35^S\]methionine-labeled *H*. *pylori* (2.5 × 10^8^), nonlabeled host cells (5 × 10^6^ per plate) were incubated for 5 h at 37°C and washed three times with PBS. The 1% Triton X-100--soluble fraction was immunoprecipitated with antiphosphotyrosine antibody (mAb PY-20) and separated by SDS-PAGE (6.5% polyacrylamide). The dried gels were scanned by an radioanalytic imaging system (Fuji BAS1500; Fuji Photo Film Co.). For labeling of host epithelial cells with \[^35^S\]methionine, epithelial cells (5 × 10^6^ per plate) were incubated in 2 ml of methionine- and FBS-free RPMI medium containing 200 μCi \[^35^S\]methionine for 5 h at 37°C. After washing with PBS at room temperature, the labeled cells were resuspended in fresh RPMI containing 10% FBS and added to nonlabeled *H*. *pylori* (2.5 × 10^8^).

Construction of cagA::Km Mutant of H. pylori.
---------------------------------------------

The *cagA*::Km mutant of *H*. *pylori* ATCC43579 was constructed by the following method: A 2.0-kb green fluorescent protein gene and kanamycin-resistant cassette were ligated into the HincII site (2,352 nucleotides) of the *cagA* gene (pCR*cagA*-GK; reference 22), and the resulting plasmid, designated pCR*cagA*-GK, was introduced into ATCC43579 by electroporation. Kanamycin-resistant transformants were screened for allelic exchange of *cagA*-GK with the wild-type *cagA* gene by PCR. The disruption of the *cagA* gene was further confirmed by Southern hybridization using a *cagA*-specific DNA probe and by immunoblot with an anti-CagA polyclonal antibody [22](#R22){ref-type="bib"}.

Peptide Mapping, Amino Acid Sequence, and Nucleotide Sequence.
--------------------------------------------------------------

For peptide mapping of the tyrosine-phosphorylated 145-kD protein, the 145-kD protein sample was prepared by immunoprecipitation with antiphosphotyrosine mAb PY-20 from lysates of epithelial cells infected by *H*. *pylori* (NCTC11637; in vivo sample) or from the reaction mixtures containing bacterial and epithelial cell lysates incubated in the phosphorylation reaction buffer in vitro (in vitro sample). The samples were separated on a 7.5% polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. The 145-kD protein bands were then subjected to direct peptide sequencing analysis as follows: The 145-kD protein bands excised from the gel were treated with 50 mM Tris/HCl buffer, pH 8.5, containing lysyl endopeptidase for 20 h at 35°C using the in-gel digestion method described by Rosenfeld et al. [23](#R23){ref-type="bib"}. The digestion solution was subjected to reverse-phase HPLC (column: TSKgel ODS-80Ts QA, 2.0 × 250 mm; TOSOH), and the peptide fragments were resolved. For amino acid sequencing of internal portions of the 145-kD protein, three major digested peptide fragments from in vitro or in vivo samples designated for sequences 1, 2, and 3 were subjected to an amino acid sequence analyzer (HP G1005A Protein Sequencing Systems; Hewlett-Packard Co.). For nucleotide sequencing of the DNA segments encoding sequences 1, 2, and 3, each of the DNA sequences were amplified by PCR from the chromosomal DNA of *H*. *pylori* NCTC11637 using oligonucleotide primers (sequence 1: sense, 5′-AAGGAGAACAATGACTAACGAA-3′, and antisense, 5′-CTGCAAAAGATTGTTTGGCAGA-3′; sequence 2: sense, 5′-GGCAATGGTGGTCCTGGAGCTAGGC-3′, and antisense, 5′-GGAAATCTTTAATCTCAGTTCGG-3′; sequence 3: sense, 5′-ATTTCAAATACACCAACGCCTCCA-3′, and antisense, 5′-TTGCTTGCGTTACCTTGCTG-3′).

PCR was performed under the following conditions: 95°C for 5 min; 25 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min; and 72°C for 7 min. PCR products were purified using concentrator columns (Centricon-100; Amicon, Inc.) according to the manufacturer\'s instructions. Direct sequencing was performed on both strands using the fluorescent dideoxy terminator method (ABI Prism Dye Terminator Cycle Sequencing Ready Reaction Kit with AmpliTaq DNA polymerase, FS; Perkin-Elmer Corp.). Sequences were analyzed using a DNA sequencer (model 310; Applied Biosystems, Inc.) according to the manufacturer\'s protocol.

Results
=======

H. pylori Attachment to Gastric Epithelial Cells Induces Tyrosine Phosphorylation of a 145-kD Protein.
------------------------------------------------------------------------------------------------------

To characterize the tyrosine phosphorylation of a 145-kD protein induced in epithelial cells infected with *H*. *pylori*, MKN45 or AGS cells were infected with *H*. *pylori* NCTC11637, and 5 h after infection, the epithelial cells lysates were examined for protein tyrosine phosphorylation by immunoblotting with an antiphosphotyrosine antibody (RC-20). Upon attachment of *H*. *pylori* to the epithelial cells, a tyrosine-phosphorylated 145-kD protein was detected, whereas no phosphorylated protein ∼145 kD in size was detected in either of the cell lines without *H*. *pylori* infection ([Fig. 1](#F1){ref-type="fig"} A). To further characterize the appearance of the phosphorylated 145-kD protein in the epithelial cells, the MKN45 cells were sampled 15 min--24 h after infection and examined for protein phosphorylation by immunoblotting with antiphosphotyrosine antibody RC-20. As shown in [Fig. 1](#F1){ref-type="fig"} B, the tyrosine phosphorylation of a 145-kD protein could be seen at 15 min, increased to a maximum level at 5--10 h, and declined to a low level 24 h after infection.

To confirm that the 145-kD protein was tyrosine phosphorylated, MKN 45 cells were treated with various concentrations of genistein, a tyrosine kinase inhibitor, and the cells were infected by *H*. *pylori* for 5 h. As shown in [Fig. 1](#F1){ref-type="fig"} C, phosphorylation of the 145-kD protein was abrogated at 100 μg/ml (370 μM). In contrast, treatment by various concentrations of orthovanadate, a tyrosine phosphatase inhibitor, increased the level of tyrosine phosphorylation of the 145-kD protein ([Fig. 1](#F1){ref-type="fig"} D), implying that protein tyrosine kinase and protein tyrosine phosphatase activities are involved in the phosphorylation of the 145-kD protein.

Infection of Gastric Epithelial Cells by H. pylori Clinical Isolates Induces Diverse Tyrosine-Phosphorylated Proteins.
----------------------------------------------------------------------------------------------------------------------

To further investigate the tyrosine-phosphorylated protein, *H*. *pylori* clinical isolates from Japanese patients with gastric ulcer or gastric cancer were examined for their ability to induce tyrosine phosphorylation in MKN45 or AGS cells. All of the clinical isolates elicited tyrosine phosphorylation of 130--135-kD proteins in both epithelial cells ([Fig. 2](#F2){ref-type="fig"}), although the level of tyrosine phosphorylation was lower than that displayed by NCTC11637 or NCTC11916, indicating that the size variation in the tyrosine-phosphorylated proteins was dependent on the infecting *H*. *pylori* strains but not on the epithelial cell lines.

In Vitro Phosphorylation Assay of Tyrosine-Phosphorylated Proteins.
-------------------------------------------------------------------

To determine whether the 145-kD phosphorylated protein evoked in the epithelial cells infected with *H*. *pylori* is a host cellular protein [13](#R13){ref-type="bib"}, reconstitution experiments were carried out using *H*. *pylori* and epithelial cell lysates in vitro. MKN45 or AGS cell lysates were or were not combined with *H*. *pylori* lysates (from NCTC11637), incubated in a phosphorylation reaction buffer containing ATP and cations for 10 min at 37°C (see Materials and Methods), analyzed by SDS-PAGE, and immunoblotted with antiphosphotyrosine RC-20. As shown in [Fig. 3](#F3){ref-type="fig"} A, a 145-kD protein was only tyrosine phosphorylated in a combination of *H*. *pylori* and epithelial cell lysates. Similarly, when bacterial lysates from each of seven *H*. *pylori* clinical isolates combined with MKN45 cell lysates were incubated in the phosphorylation reaction buffer, diverse phosphorylated proteins ∼130--135 kD in size were detected ([Fig. 3](#F3){ref-type="fig"} B). Importantly, the size variations with GU301, GU303, GC401, or GC402 were comparable to those seen in the epithelial cells infected with the corresponding *H*. *pylori* strains ([Fig. 2](#F2){ref-type="fig"}). Under the same conditions, neither *H*. *pylori* lysate alone nor the epithelial cell lysate alone in the phosphorylation reaction buffer induced protein tyrosine phosphorylation (data not shown), strongly suggesting that the size variation of the phosphorylated protein was dependent on the bacterial strain.

To verify that the 145-kD proteins phosphorylated in vitro and in vivo were identical, the 145-kD protein was collected by immunoprecipitation with antiphosphotyrosine mAb PY-20 from in vitro or in vivo samples and digested with lysyl endopeptidase using an in-gel digestion method (see Materials and Methods). The HPLC profiles of each digested segment of the 145-kD proteins were similar (data not shown). To further ascertain whether the tyrosine-phosphorylated protein was of *H*. *pylori* origin, NCTC11637 bacterial lysate was phosphorylated in phosphorylation reaction buffer in vitro using nonreceptor protein tyrosine kinase, c-Src kinase, or receptor protein tyrosine kinase EGF receptor kinase. Indeed, a 145-kD protein was tyrosine phosphorylated, as determined by immunoblotting with antiphosphotyrosine RC-20 (data not shown), raising the possibility that the 145-kD tyrosine-phosphorylated protein induced in epithelial cells infected with *H*. *pylori* is from the infecting bacteria.

Demonstration of the 145-kD Protein from H. pylori.
---------------------------------------------------

To directly demonstrate that the tyrosine-phosphorylated 145-kD protein was of *H*. *pylori* origin, *H*. *pylori* strain NCTC11637 and AGS cells were labeled with \[^35^S\]methionine separately, and then the nonlabeled epithelial cells were infected with the \[^35^S\]methionine-labeled bacteria for 5 h (the \[^35^S\]methionine-labeled epithelial cells were infected with nonlabeled bacteria for 5 h). The infected AGS cells were lysed with 1% Triton X-100, and the soluble fraction was immunoprecipitated with antiphosphotyrosine mAb PY-20. Analysis of the precipitates revealed a 145-kD protein labeled by \[^35^S\]methionine ([Fig. 4](#F4){ref-type="fig"}, lane 2). Although the radioactivity of the tyrosine-phosphorylated protein was low, the labeled 145-kD protein was reproducibly detected in three independent experiments. Under the same conditions, the 145-kD protein was not detected in antiphosphotyrosine mAb PY-20 immunoprecipitates from labeled bacteria alone ([Fig. 4](#F4){ref-type="fig"}, lane 4) or from labeled AGS cells infected with nonlabeled *H*. *pylori* (lane 7). As the CagA protein of *H*. *pylori* ranges in size from 120 to 140 kD in different strains [11](#R11){ref-type="bib"} [22](#R22){ref-type="bib"} and our data suggested that the 145-kD protein was derived from *H*. *pylori*, we reasoned that the tyrosine-phosphorylated protein was CagA. The lysates of epithelial cells infected with the \[^35^S\]methionine-labeled *H*. *pylori* were immunoprecipitated by an anti-CagA polyclonal antibody. As shown in [Fig. 4](#F4){ref-type="fig"} (lane 3), a protein corresponding to 145 kD that was labeled by \[^35^S\]methionine was immunoprecipitated with anti-CagA antibody.

Amino Acid Sequence of the 145-kD Protein.
------------------------------------------

The amino acid sequence of three internal segments of the 145-kD protein prepared from in vitro-- or in vivo--phosphorylated sample was determined. The 145-kD phosphorylated protein was digested with lysyl endopeptidase as described above, and the resulting three internal segments, named segment 1, 2, and 3, were subjected to amino acid sequence analysis by Edman chemistry (see Materials and Methods). The amino acid sequences in segment 1, 2, and 3 yielded the sequences DNLIDIGSSIK, NQQGDNVATLINVHMK, and IFALINK, respectively, which were identical to the deduced sequences of the three internal *cagA* sequences of *H*. *pylori* NCTC11637 that were amplified by PCR using three sets of oligonucleotide primers, as described in Materials and Methods ([Fig. 5](#F5){ref-type="fig"}). These sequences were further confirmed to be present in the CagA sequence deduced from the whole *cagA* gene sequence of NCTC11637 (available from EMBL/GenBank/DDBJ under accession nos. NCTC11637, AF202973 and GC401, AF202972). The amino acids of segments 1, 2, and 3 were almost identical to the respective internal amino acid sequences of the CagA protein deduced from the nucleotide sequences of the *cagA* gene of *H*. *pylori* CCUG17874 [11](#R11){ref-type="bib"}; sequence 1 (segment 1), sequence 2 (segment 2), and sequence 3 (segment 3) of the CagA protein from NCTC11637 corresponded to the internal CagA sequences of Asp^97^--Lys^107^, Asn^339^--Lys ^354^, and Ile^655^--Lys^661^, respectively. Based on the results, we concluded that the 145-kD tyrosine-phosphorylated protein induced in the epithelial cells infected with *H*. *pylori* is the CagA protein.

Intracellular CagA Protein Can Only Be Tyrosine Phosphorylated.
---------------------------------------------------------------

To confirm the above results, the 145-kD tyrosine-phosphorylated protein induced in AGS cells infected with *H*. *pylori* NCTC11637 was reinvestigated by immunoprecipitation with anti-CagA antibody. As shown in [Fig. 6](#F6){ref-type="fig"} A, the 145-kD protein precipitated with anti-CagA antibody was detected by immunoblotting with antiphosphotyrosine RC-20. As the CagA protein of *H*. *pylori* is secreted [24](#R24){ref-type="bib"} [25](#R25){ref-type="bib"} [26](#R26){ref-type="bib"} [27](#R27){ref-type="bib"} [28](#R28){ref-type="bib"}, we examined whether the 145-kD protein was also secreted into the culture supernatant during infection. Immunoblot analysis with the anti-CagA antibody revealed that the 145-kD protein was present in the culture medium, the levels of which increased by 5--10 h after infection ([Fig. 6](#F6){ref-type="fig"} B). Importantly, protein tyrosine phosphorylation could not be detected in the culture supernatant at all ([Fig. 6](#F6){ref-type="fig"} B), indicating that the intracellular CagA protein can only undergo tyrosine phosphorylation.

We reexamined the tyrosine-phosphorylated proteins induced in epithelial cells infected with *H*. *pylori* GU303 or GC401 by immunoblotting with the anti-CagA antibody. The 130-kD phosphorylated proteins were also detected by the anti-CagA antibody ([Fig. 6](#F6){ref-type="fig"} C). *H*. *pylori* ATCC43579 and its isogenic *cagA*::Km mutant were similarly tested. Whereas the wild-type *H*. *pylori* gave rise to the 145-kD tyrosine-phosphorylated protein, the isogenic *cagA*::Km mutant failed to generate the phosphorylated protein in the infected epithelial cells ([Fig. 6](#F6){ref-type="fig"} D).

Discussion
==========

In this study, we investigated the tyrosine-phosphorylated 145-kD protein induced in gastric epithelial cells infected with *H*. *pylori* and identified the phosphorylated protein as the *cagA* gene product of *H*. *pylori*. Our conclusion was based on the following results: (a) attachment of different clinical isolates, including several standard *H*. *pylori* strains, to epithelial cells evoked diverse sizes of tyrosine-phosphorylated proteins ranging from 130 to 145 kD; (b) when bacterial lysates from the clinical isolates were combined with host cell lysates in vitro, diverse sizes of tyrosine-phosphorylated proteins were also evoked; (c) when epithelial cells were infected with \[^35^S\]methionine-labeled *H*. *pylori* NCTC11637, a radiolabeled 145-kD protein was immunoprecipitated by antiphosphotyrosine mAb PY-20 and anti-CagA polyclonal antibody; (d) infection of epithelial cells by a *cagA*::Km mutant of *H*. *pylori* failed to induce the tyrosine phosphorylation of the 145-kD protein; and (e) the amino acid sequence of the tyrosine-phosphorylated 145-kD protein was identical to the CagA sequence of *H*. *pylori*.

Adherence of *H*. *pylori* to gastric epithelial cells can induce host cellular responses, including the reorganization of actin cytoskeletons [29](#R29){ref-type="bib"}, the tyrosine phosphorylation of a 145-kD protein [13](#R13){ref-type="bib"}, and release of IL-8 [15](#R15){ref-type="bib"} [18](#R18){ref-type="bib"} [21](#R21){ref-type="bib"}. The 145-kD phosphorylated protein induced in gastric epithelial cells infected with *H*. *pylori* strain 87A300 was originally reported by Segal and colleagues, who proposed that the 145-kD protein was a host cellular component [13](#R13){ref-type="bib"} [14](#R14){ref-type="bib"}. In a subsequent study, they examined type I *H*. *pylori* strains together with various *cag* insertion mutants (*cagE*, *cagF*, *cagG*, *cagH*, *cagI*, *cagL*, *cagN*, and *cagM*) for their ability to induce tyrosine phosphorylation of the 145-kD protein or IL-8 production and showed that whereas type I strains were able to induce protein phosphorylation and IL-8 production, all of the *cag* insertion mutants except for *cagN* failed to induce the protein phosphorylation and IL-8, indicating that for all of the *cag* PAI mutants, there was a correlation between the ability to phosphorylate the 145-kD protein and induction of IL-8 [15](#R15){ref-type="bib"}. Based on the effects of various kinase inhibitors on phosphorylation of the 145-kD protein and IL-8 induction as well as on the different inhibitory effect, Segal and colleagues proposed that two distinct signal pathways participate independently in stimulation of IL-8 release and protein tyrosine phosphorylation. Censini et al. [7](#R7){ref-type="bib"} reported that KATO-III cells infected with the *cagA* or *cagN* mutant were still able to stimulate IL-8 release, whereas the other *cag* mutants (*cagE*, *cagG*, *cagH*, *cagI*, *cagL*, and *cagM*) failed to induce IL-8 production and NF-κB activation [15](#R15){ref-type="bib"} [30](#R30){ref-type="bib"}. Therefore, these studies have suggested that some of the *cag* genes in the *cag* PAI, including the *cagA* gene, could be involved in the induction of phosphorylation of the 145-kD protein [7](#R7){ref-type="bib"}.

In this study, we confirmed that infection of gastric epithelial cells by *H*. *pylori* strains such as NCTC11637, NCTC11916, and ATCC43579 induced tyrosine phosphorylation of a 145-kD protein. Interestingly, when AGS cells were infected with various *H*. *pylori* clinical isolates, tyrosine-phosphorylated proteins ranging from 130 to 135 kD in size were evoked that were also reproducibly induced in the infected MKN45 cells, raising the possibility that the tyrosine-phosphorylated protein was not a host cellular protein but rather derived from *H*. *pylori*. This notion agreed with the results of in vitro protein phosphorylation assays using bacterial lysates and AGS cell lysates, where the sizes of the phosphorylated proteins were comparable to those induced in epithelial cells infected with *H*. *pylori* clinical isolates ([Fig. 3](#F3){ref-type="fig"}). As the CagA protein displayed considerable size variation ranging from 120 to 140 kD in different *H*. *pylori* clinical isolates, a consequence of the intragenic repeat sequences in the 3′ portion of the *cagA* gene [11](#R11){ref-type="bib"}, we reasoned that the tyrosine-phosphorylated 145-kD protein, including the diverse phosphorylated proteins induced in epithelial cells infected with NCTC11637 or various clinical isolates, *H*. *pylori* strains would be the *cagA* product. Examination of the tyrosine-phosphorylated 145-kD protein using anti-CagA polyclonal antibody and the direct amino acid sequencing supported our premise. Interestingly, the levels of phosphorylation of the 130--135-kD protein (identified as CagA) also varied among *H*. *pylori* clinical isolates, with somewhat lower levels of phosphorylation than those induced by *H*. *pylori* NCTC11637 or NCTC11916. The CagA sequences deduced from the nucleotide sequencing of the *cagA* gene in *H*. *pylori* CCUG1784 (128-kD CagA) and ACTT43526 (138-kD CagA) had two and five copies of repeat Glu-Pro-Ile-Tyr-Ala (EPIYA) sequences at the 3′ region, respectively [11](#R11){ref-type="bib"} [22](#R22){ref-type="bib"}. Similarly, the CagA sequences deduced from the nucleotide sequencing of the *cagA* gene in NCTC11637 and GC401 revealed that CagA of NCTC11637 (139-kD CagA) and GC401 (131-kD CagA) contained five and three copies of EPIYA sequences at the 3′ region, respectively. Interestingly, one of the putative tyrosine phosphorylation sites in the EPIYA sequence, which is part of the Pro(Leu)-Glu-Glu-Pro-Ile-Tyr-Ala (PEEPIYA or LEEPIYA) sequence, is similar to the PEEHIYD sequence in the Tir protein of enteropathogenic *Escherichia coli* (EPEC; reference 31). Notably, the tyrosine phosphorylation at the PEEHIYD sequence of the EPEC Tir protein is essential for EPEC induction of the actin nucleation activity beneath the bacterium and tight bacterial adherence to epithelial cells [32](#R32){ref-type="bib"}. Although the preferential tyrosine phosphorylation sites in the CagA protein remain to be determined, it is likely that the different levels of phosphorylation of the CagA proteins in epithelial cells induced by *H*. *pylori* clinical isolates could partly depend on the numbers of repeated EPIYA sequences present in each CagA protein.

As the CagA protein can be secreted onto the bacterial surface and also released into the culture supernatant even in the absence of a typical leader peptide sequence [11](#R11){ref-type="bib"} [24](#R24){ref-type="bib"} [25](#R25){ref-type="bib"} [26](#R26){ref-type="bib"} [27](#R27){ref-type="bib"} [28](#R28){ref-type="bib"}, CagA secretion is thought to be exported by a *sec*-independent secretion system [11](#R11){ref-type="bib"} [19](#R19){ref-type="bib"}. In this study, we confirmed that the 145-kD protein (and the 130--135-kD protein) was also secreted into the culture supernatant from various *H*. *pylori* strains when attached to the epithelial cells, and we identified the 145-kD protein (and the 130--135-kD proteins) as CagA. Whereas the extracellular 145-kD protein was not tyrosine phosphorylated at all, the intracellular protein was tyrosine phosphorylated. Although the precise mechanisms of CagA secretion from *H*. *pylori* into the bacterial environment or host cells remains unclear, it is tempting to speculate that *H*. *pylori* could directly deliver the CagA protein into the host cell cytoplasm through attachment to the cells, and the internalized CagA protein could then undergo tyrosine phosphorylation by host cellular tyrosine kinases. Importantly, some of the *cag*-encoded proteins such as CagE, CagT, *cag*ORF524, *cag*ORF525, *cag*ORF527, *cag*ORF528, and *cag*ORF996 have sequence similarities to well known proteins composing the type IV export machineries of *E. coli*, *Bordetella pertussis*, *A. tumefaciens*, *Legionella pneumophila*, *Rickettsia prowazekii*, and *Brucella suis* [19](#R19){ref-type="bib"} [20](#R20){ref-type="bib"} [33](#R33){ref-type="bib"} [34](#R34){ref-type="bib"} [35](#R35){ref-type="bib"}. The type IV export systems specialize in transfer of a variety of multimolecular complexes across the bacterial membrane to the extracellular space or into target host cells [19](#R19){ref-type="bib"} [20](#R20){ref-type="bib"}. Furthermore, Segal et al. showed that mutations in some of the *cag* genes such as *cagE*, *cagF*, *cagG*, *cagH*, *cagI, cagL,* and *cagM* failed to induce tyrosine phosphorylation of the 145-kD protein [15](#R15){ref-type="bib"}. It is thus intriguing to speculate that the delivery of CagA from *H*. *pylori* into the culture supernatant and the attached epithelial cells could be via the putative type IV export system.

Although the precise role of tyrosine phosphorylation of intracellular CagA protein in the pathogenesis of *H*. *pylori* remains to be elucidated, the behavior of CagA protein observed in this study is reminiscent of the EPEC Tir protein; the Tir protein can be directly delivered from EPEC into attached epithelial cells though the type III secretion machinery, and the translocated protein undergoes tyrosine phosphorylation in the host cell cytoplasm [31](#R31){ref-type="bib"}. In addition, both *H*. *pylori* and EPEC can attach tightly to the epithelial cells, an attachment through which pathogens can induce a local rearrangement of actin cytoskeletons, including pedestal formation beneath the bacterium and release of IL-8 [13](#R13){ref-type="bib"} [15](#R15){ref-type="bib"} [36](#R36){ref-type="bib"} [37](#R37){ref-type="bib"}. However, CagA and Tir have no amino acid sequence similarity. Indeed, Tir possesses two transmembrane domains, whereas CagA has no such domains, and CagA is a very hydrophilic protein [11](#R11){ref-type="bib"} [31](#R31){ref-type="bib"}. Although the tyrosine-phosphorylated Tir protein has been implicated in induction of actin condensation beneath the bacterium and serves as the receptor for binding to the intimin protein, the tyrosine-phosphorylated CagA protein seems to have no such specific role [15](#R15){ref-type="bib"} [31](#R31){ref-type="bib"} [38](#R38){ref-type="bib"}. Instead, CagA has been implicated in determination of the intensity of inflammation in the gastric epithelium, a key event in the development of gastric diseases associated with *H*. *pylori* infection [9](#R9){ref-type="bib"} [12](#R12){ref-type="bib"}. Thus, based on our results, the phosphorylated CagA protein may also play a crucial role in promoting the inflammatory responses of gastric mucosa to *H*. *pylori* infection. The identification of the 145-kD tyrosine-phosphorylated protein as the *cagA* gene product of *H*. *pylori* should provide further insight into the precise role of the CagA protein in the pathogenesis of *H*. *pylori* as well as in the development of duodenitis, duodenal ulcers, and gastric cancer.
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Immunoblot analysis of gastric epithelial cells infected with *H*. *pylori* by antiphosphotyrosine antibody RC-20. (A) Tyrosine phosphorylation of a 145-kD protein in MKN45 or AGS cells induced by *H*. *pylori* NCTC11637 infection. Lanes 1 and 2, lysates of uninfected MKN45 or MKN45 infected with *H*. *pylori* for 5 h; lanes 3 and 4, lysates of uninfected AGS or AGS infected with *H*. *pylori* for 5 h. Arrowhead indicates the 145-kD protein. (B) Time course for the expression of protein tyrosine phosphorylation in MKN45 cells infected with *H*. *pylori* NCTC11637. Uninfected (lane 1) or infected (lanes 2--9) MKN45 cells were examined at the indicated times (h) after bacterial infection. Effect of genistein (C) or vanadate (D) on the 145-kD protein tyrosine phosphorylation in MKN45 cells infected with *H*. *pylori* NCTC11637. Cells were treated with various concentrations of genistein or vanadate for 30 min at 37°C before the infection. The epithelial cells infected with *H*. *pylori* for 5 h were sampled at the indicated concentration, and the protein tyrosine phosphorylation in the cell lysates was examined by the same methods as in A.
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![Diversity of tyrosine-phosphorylated large proteins induced in epithelial cells infected with various *H*. *pylori* strains. Protein tyrosine phosphorylation in MKN45 (A) and AGS cells (B) infected with various clinical isolates of *H*. *pylori* for 5 h. Lane 1, uninfected control; lanes 2--7 represent protein tyrosine phosphorylation induced in epithelial cells infected with NCTC11916, NCTC11637, GU301, GU303, GC401, and GC402, respectively. Arrowhead indicates the tyrosine-phosphorylated 145-kD protein; arrow indicates the phosphorylated large proteins in epithelial cells infected with various clinical isolates.](JEM991610.f2){#F2}

![In vitro tyrosine phosphorylation of the 145-kD protein. (A) Tyrosine phosphorylation of a 145-kD protein induced by a combination of *H*. *pylori* NCTC11637 and MKN45 (or AGS) cell lysates. Epithelial cell lysates with or without bacterial lysates were added to a phosphorylation reaction buffer and incubated for 10 min at 30°C. The 145-kD protein was detected by immunoblotting with antiphosphotyrosine antibody RC-20. (B) Tyrosine phosphorylation of a large protein induced by the combination of various *H*. *pylori* strains and MKN45 cell lysates. Lanes 1--9: control (without *H*. *pylori* lysate), NCTC11637, GU301, GU303, GU304, GU305, GU306, GC401, and GC402, respectively. Arrowhead and arrow indicate the tyrosine-phosphorylated 145-kD and other proteins, respectively.](JEM991610.f3){#F3}

![Demonstration of the tyrosine-phosphorylated 145-kD protein derived from *H*. *pylori*. AGS cells were infected with \[^35^S\]methionine-labeled or nonlabeled *H*. *pylori* for 5 h at 37°C, and the cell lysates prepared with 1% Triton X-100 were immunoprecipitated by an antiphosphotyrosine mAb PY-20 or an anti-CagA polyclonal antibody. The precipitated proteins were separated by SDS-PAGE and analyzed using a radioanalytic imaging system. Arrowhead indicates the 145-kD protein. Lanes 1--3, AGS infected with \[^35^S\]methionine-labeled *H*. *pylori*; lanes 4 and 5, \[^35^S\]methionine-labeled *H*. *pylori* alone; lanes 6--8, \[^35^S\]methionine-labeled AGS infected with nonlabeled *H*. *pylori*; lanes 1 and 6, the 1% Triton X-100--soluble fraction precipitated by control normal IgG; lanes 2, 4, and 7, the 1% Triton X-100--soluble fraction precipitated by antiphosphotyrosine mAb PY-20; and lanes 3, 5, and 8, the 1% Triton X-100--soluble fraction precipitated by anti-CagA polyclonal antibody. Note that the \[^35^S\]methionine-labeled band being lower than that of 145-kD protein in lanes 3 and 5 may be bacterial protein(s) cross-reacted with the polyclonal anti-CagA antibody.](JEM991610.f4){#F4}

###### 

Amino acid sequences of the tyrosine-phosphorylated 145-kD protein. Amino acid sequences of the three internal segments of the tyrosine-phosphorylated 145-kD protein (145-kD seg-1, -2, and -3) from in vitro sample (the reactant of NCTC11637 and MKN45 cell lysates incubated in the phosphorylation reaction buffer in vitro), the amino acid sequences deduced from nucleotide sequences of the DNA segments encoding sequences 1, 2, and 3 from NCTC11637 (NCTC 11637 seg-1, -2, and -3), or the amino acid sequences deduced from the nucleotide sequences of the corresponding *cagA* sequence from CCUG17874 (CCUG 17874 seg-1, -2, and -3; reference 11).
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###### 

Tyrosine phosphorylation of CagA protein induced in *H*. *pylori*--infected epithelial cells. (A) Detection of the tyrosine phosphorylation of CagA protein in AGS cells induced by *H*. *pylori* infection. AGS cells infected with *H*. *pylori* NCTC11637 at indicated times after infection were lysed in a 1% Triton X-100 lysis buffer, and the soluble fraction was immunoprecipitated with an anti-CagA polyclonal antibody. The precipitates were separated by SDS-PAGE and then immunoblotted with antiphosphotyrosine antibody RC-20 or anti-CagA polyclonal antibody. (B) Absence of tyrosine-phosphorylated CagA protein in the culture supernatants. The culture supernatants used for the AGS cells infected with *H*. *pylori* NCTC11637 at the indicated times were subjected to the same immunoblot analysis as in A. The rightmost lane represents the tyrosine phosphorylation of CagA protein in AGS cells induced by *H*. *pylori* 10 h after infection. (C) Tyrosine phosphorylation of CagA protein in AGS cells induced by infection with *H*. *pylori* strains NCTC11637, GU303, and GC401. The leftmost lane shows noninfected control, and the second lane on the left shows NCTC11637 control. Top panel: tyrosine-phosphorylated CagA proteins detected in AGS cells infected with *H*. *pylori*; bottom panel: the same blot reprobed with the anti-CagA polyclonal antibody. (D) Tyrosine phosphorylation of CagA protein in AGS cells induced by infection with ATCC43579 and the *cagA*::Km mutant. Arrowhead indicates the 145-kD protein.
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